Ixazomib, Daratumumab and Low Dose Dexamethasone in Intermediate-Fit Patients with Newly Diagnosed Multiple Myeloma (NDMM); Results of Induction Treatment of the Phase II HOVON 143 StudyKaz Groen,Claudia A.M. Stege,Kazem Nasserinejad,Koen de Heer,Roel J.W. Van Kampen,Maria B.L. Leijs,Noortje Thielen,Matthijs Westerman,Ka Lung Wu,Inge Ludwig,Djamila Issa,Gerjo A. Velders,Marie-Christiane Vekemans,Niels W.C.J. van de Donk,Gert-Jan Timmers,Pieter Sonneveld,Maarten R. Seefat,Fransien Croon-de Boer,Lidwine W. Tick,Ellen van der SpekBlood(2021)引用 3|浏览12暂无评分摘要Introduction更多查看译文AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要